期刊文献+

血浆miR-379、miR-195、Gas6水平早期检测在AMI患者中的应用价值

Application value of early detection of plasma miR-379,miR-195 and Gas6 levels in patients with AMI
下载PDF
导出
摘要 目的分析血浆微小RNA-379(miR-379)、微小RNA-195(miR-195)、生长停滞特异性蛋白6(Gas6)水平早期检测在急性心肌梗死(AMI)患者中的应用价值。方法选取2021年5至2022年7月于首都医科大学附属北京世纪坛医院心内科住院治疗的265例患者,分为AMI组(n=127)和非AMI组(n=138),选取同期120名健康体检者设为对照组。比较三组入组时的血浆miR-379、miR-195表达量及Gas6水平;采用Pearson相关系数分析AMI患者入组时的血浆Gas6水平与miR-379、miR-195表达量的关系;采用受试者工作曲线(ROC)分析入组时的血浆Gas6水平及miR-379、miR-195表达量对早期AMI的诊断价值。结果三组入组时的血浆miR-379、miR-195、Gas6水平比较差异有统计学意义(P<0.05);血浆miR-379水平比较:AMI组<非AMI组<对照组,miR-195、Gas6水平比较:AMI组>非AMI组>对照组,差异有统计学意义(P<0.05)。Pearson相关系数分析显示,Gas6与miR-379水平呈负相关(P<0.05),与miR-195水平呈正相关(P<0.05)。ROC结果显示,血浆miR-379、miR-195、Gas6水平单独诊断早期AMI具有一定局限性(AUC=0.808、0.718、0.752),三者联合诊断的效能更佳(AUC=0.879)。结论血浆miR-379、miR-195、Gas6水平在AMI患者中异常表达,三指标可作为AMI早期疾病诊断的参考指标。 Objective To analyze the application value of early detection of plasma microRNA-379(miR-379),microRNA-195(miR-195)and growth arrest specific protein 6(Gas6)levels in patients with acute myocardial infarction(AMI).Methods 265 patients who were hospitalized in the Department of Cardiology,Beijing Shijitan Hospital Affiliated to Capital Medical University were selected between May 2021 and July 2022,and were classified into the AMI group(n=127)and the non-AMI group(n=138).120 healthy subjects with physical examination during the same period were selected as the control group.The expression levels of plasma miR-379 and miR-195 and Gas6 at admission were compared among the three groups.Pearson correlation coefficient analysis was used to analyze the relationship between plasma Gas6 level and expression levels of miR-379 and miR-195 in patients with AMI at admission.The diagnostic value of plasma Gas6 level and expression levels of miR-379 and miR-195 at admission on early AMI was analyzed by the receiver operating characteristic curve(ROC).Results There were statistically significant differences in the plasma levels of miR-379,miR-195,and Gas6 among the three groups at enrollment(P<0.05).Comparison of plasma miR-379 levels:AMI group<non-AMI group<control group(P<0.05).Comparison of miR-195 and Gas6 levels:AMI group>non-AMI group>control group(P<0.05).Pearson correlation coefficient analysis showed that Gas6 was negatively correlated with the level of miR-379(P<0.05)and positively correlated with the level of miR-195(P<0.05).The ROC results showed that plasma miR-379,miR-195 and Gas6 alone had certain limitations in diagnosing early AMI(AUC=0.808,0.718 and 0.752),and the combination of the three had better efficiency(AUC=0.879).Conclusion The levels of plasma miR-379,miR-195 and Gas6 are abnormally expressed in patients with AMI,and these three indicators can be used as reference indicators for the early diagnosis of AMI.
作者 崔雅璇 陈旭 刘倩 孙佳乐 CUI Yaxuan;CHEN Xu;LIU Qian;SUN Jiale(Department of Emergency,Beijing Shijitan Hospital Affiliated to Capital Medical University,Beijing,China,100038)
出处 《分子诊断与治疗杂志》 2024年第1期89-92,97,共5页 Journal of Molecular Diagnostics and Therapy
基金 北京市科技计划项目(Z202300002010021)。
关键词 血浆微小RNA-379 微小RNA-195 生长停滞特异性蛋白6 急性心肌梗死 Plasma microRNA-379 MicroRNA-195 Growth arrest specific protein 6 Acute myocardial infarction
  • 相关文献

参考文献7

二级参考文献86

  • 1李名兰,潘碧云,陈仕银,温达,王燕英.血尿素氮水平对冠心病患者经皮冠状动脉介入术后远期预后的影响[J].内科急危重症杂志,2020(2):129-133. 被引量:3
  • 2Roffi M, Patrono C, Collet JP, et al. 2015 ESC guide- lines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2016, 37 (3): 267-315.
  • 3Nabi F, Chang SM, Xu J, et al. Assessing risk in acute chest pain: the value of stress myocardial perfusion imaging in patients admitted through the emergency department[J]. J Nucl Cardiol, 2012, 19 (2): 233-243.
  • 4Shah BN, Balaji G, Alhajiri A, et al. Incremental dia- gnostic and prognostic value of contemporary stress echocardiography in a chest pain unit: mortality and morbidity outcomes from a real-world setting [J]. Cardiovasc Imaging, 2013, 6 (2): 202-209.
  • 5Hulten E, Pickett C, Bittencourt MS, et al. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta- analysis of randomized, controlled trials [J]. J Am Coll Cardiol,2013,61(8):880-892.
  • 6Mueller C, Giannitsis E, Christ M, et al. Muhicenter evaluation of a 0-hour / 1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T [J]. Ann Emerg Med, 2016, pii: S0196-0644 (15) 01501-01502.
  • 7Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T [J]. Arch Intern Med, 2012, 172 (16): 1211-1218.
  • 8Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J]. Eur Heart J, 2012, 33 (20): 2569-2619.
  • 9Fox KA, Fitzgerald G, Puymirat E, et al. Should pa- tients with acute coronary disease be stratified for management according to their risk derivation, external validation and outcomes using the updated GRACE risk score[J]. BMJ Open, 2014, 4 (2): e4425.
  • 10Abu-Assi E, Raposeiras-Roubin S, Lear P, et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome [J]. Eur Heart J Acute Cardiovasc Care, 2012, 1 (3): 222- 231.

共引文献250

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部